James William Gaynor1, Samuel Parry2, Julie S Moldenhauer3, Rebecca A Simmons4, Jack Rychik5, Richard F Ittenbach6, William W Russell1, Erin Zullo1, John Laurenson Ward1, Susan C Nicolson7, Thomas L Spray1, Mark P Johnson3. 1. Division of Cardiac Surgery, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. 2. Division of Maternal Fetal Medicine, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, USA. 3. Center for Fetal Diagnosis and Therapy, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. 4. Division of Neonatology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. 5. Division of Pediatric Cardiology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. 6. Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. 7. Division of Pediatric Cardiac Anesthesiology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Abstract
OBJECTIVES: Pregnancies with congenital heart disease in the foetus have an increased prevalence of pre-eclampsia, small for gestational age and preterm birth, which are evidence of an impaired maternal-foetal environment (MFE). METHODS: The impact of an impaired MFE, defined as pre-eclampsia, small for gestational age or preterm birth, on outcomes after cardiac surgery was evaluated in neonates (n = 135) enrolled in a study evaluating exposure to environmental toxicants and neuro-developmental outcomes. RESULTS: The most common diagnoses were transposition of the great arteries (n = 47) and hypoplastic left heart syndrome (n = 43). Impaired MFE was present in 28 of 135 (21%) subjects, with small for gestational age present in 17 (61%) patients. The presence of an impaired MFE was similar for all diagnoses, except transposition of the great arteries (P < 0.006). Postoperative length of stay was shorter for subjects without an impaired MFE (14 vs 38 days, P < 0.001). Hospital mortality was not significantly different with or without impaired MFE (11.7% vs 2.8%, P = 0.104). However, for the entire cohort, survival at 36 months was greater for those without an impaired MFE (96% vs 68%, P = 0.001). For patients with hypoplastic left heart syndrome, survival was also greater for those without an impaired MFE (90% vs 43%, P = 0.007). CONCLUSIONS: An impaired MFE is common in pregnancies in which the foetus has congenital heart disease. After cardiac surgery in neonates, the presence of an impaired MFE was associated with lower survival at 36 months of age for the entire cohort and for the subgroup with hypoplastic left heart syndrome.
OBJECTIVES: Pregnancies with congenital heart disease in the foetus have an increased prevalence of pre-eclampsia, small for gestational age and preterm birth, which are evidence of an impaired maternal-foetal environment (MFE). METHODS: The impact of an impaired MFE, defined as pre-eclampsia, small for gestational age or preterm birth, on outcomes after cardiac surgery was evaluated in neonates (n = 135) enrolled in a study evaluating exposure to environmental toxicants and neuro-developmental outcomes. RESULTS: The most common diagnoses were transposition of the great arteries (n = 47) and hypoplastic left heart syndrome (n = 43). Impaired MFE was present in 28 of 135 (21%) subjects, with small for gestational age present in 17 (61%) patients. The presence of an impaired MFE was similar for all diagnoses, except transposition of the great arteries (P < 0.006). Postoperative length of stay was shorter for subjects without an impaired MFE (14 vs 38 days, P < 0.001). Hospital mortality was not significantly different with or without impaired MFE (11.7% vs 2.8%, P = 0.104). However, for the entire cohort, survival at 36 months was greater for those without an impaired MFE (96% vs 68%, P = 0.001). For patients with hypoplastic left heart syndrome, survival was also greater for those without an impaired MFE (90% vs 43%, P = 0.007). CONCLUSIONS: An impaired MFE is common in pregnancies in which the foetus has congenital heart disease. After cardiac surgery in neonates, the presence of an impaired MFE was associated with lower survival at 36 months of age for the entire cohort and for the subgroup with hypoplastic left heart syndrome.
Authors: Thomas A Miller; Nancy S Ghanayem; Jane W Newburger; Brian W McCrindle; Chenwei Hu; Aaron G DeWitt; James F Cnota; Felicia L Tractenberg; Victoria L Pemberton; Michael J Wolf; Jodie K Votava-Smith; Carlen G Fifer; Linda M Lambert; Amee Shah; Eric M Graham; Christian Pizarro; Jeffrey P Jacobs; Stephen G Miller; L LuAnn Minich Journal: Pediatrics Date: 2019-04-12 Impact factor: 7.124
Authors: Sara K Pasquali; Michael Gaies; Mousumi Banerjee; Wenying Zhang; Janet Donohue; Mark Russell; J William Gaynor Journal: Ann Thorac Surg Date: 2019-08-06 Impact factor: 4.330
Authors: Jill J Savla; Mary E Putt; Jing Huang; Samuel Parry; Julie S Moldenhauer; Samantha Reilly; Olivia Youman; Jack Rychik; Laura Mercer-Rosa; J William Gaynor; Steven M Kawut Journal: J Am Heart Assoc Date: 2022-01-11 Impact factor: 6.106
Authors: Martina A Steurer; Shabnam Peyvandi; Rebecca J Baer; Scott P Oltman; Christina D Chambers; Mary E Norton; Kelli K Ryckman; Anita J Moon-Grady; Roberta L Keller; Stephen C Shiboski; Laura L Jelliffe-Pawlowski Journal: J Am Heart Assoc Date: 2019-11-15 Impact factor: 5.501
Authors: Martina A Steurer; Rebecca J Baer; Edmund Burke; Shabnam Peyvandi; Scott Oltman; Christina D Chambers; Mary E Norton; Larry Rand; Satish Rajagopal; Kelli K Ryckman; Sky K Feuer; Liang Liang; Randi A Paynter; Molly McCarthy; Anita J Moon-Grady; Roberta L Keller; Laura L Jelliffe-Pawlowski Journal: J Am Heart Assoc Date: 2018-09-04 Impact factor: 5.501
Authors: I Ribera; A Ruiz; O Sánchez; E Eixarch; E Antolín; E Gómez-Montes; M Pérez-Cruz; M Cruz-Lemini; M Sanz-Cortés; S Arévalo; Q Ferrer; E Vázquez; L Vega; P Dolader; A Montoliu; H Boix; R V Simões; N Masoller; J Sánchez-de-Toledo; M Comas; J M Bartha; A Galindo; J M Martínez; L Gómez-Roig; F Crispi; O Gómez; E Carreras; L Cabero; E Gratacós; E Llurba Journal: BMC Pediatr Date: 2019-09-10 Impact factor: 2.125
Authors: Priyanka Asrani; Nelangi M Pinto; Michael D Puchalski; Zhining Ou; Robert M Silver; Erin K Zinkhan; Cara C Heuser; Amy Nance; Thomas A Miller Journal: J Am Heart Assoc Date: 2020-06-09 Impact factor: 5.501